-
March 5, 2022 Psychedelic Stocks in the Short-Term: Expectations, Catalysts, Risks and RewardWhen it comes to investing in psychedelic stocks such as MindMed (MNMD, MMED), Compass Pathways...
-
March 4, 2022 Psychedelic Business Spotlight – March 4This week in psychedelic business news: Field Trip partners with Cerebral; Benzinga forms Psychedelic Advisory...
-
March 1, 2022 Dr. Bronner’s Magic Soaps Offers Free Ketamine-Assisted Therapy to Employees"Considering all our advocacy on this issue, this employee benefit is the next logical step,"...
-
February 26, 2022 How Long Until Psychedelic Stocks Payoff?🍄🚀| MindMed (MNMD), Cybin (CYBN), Numinus (NUMI) and moreHow long until Psychedelic Stocks Payoff?🍄🚀 To sign up for the Psychedelic Stock Tips Newsletter,...
-
February 25, 2022 Psychedelic Business Spotlight – February 25This week in psychedelic business news: Core One cheapens psilocybin production; Field Trip eyes Oregon;...
-
February 22, 2022 Irwin Naturals’ Mission to Make Ketamine Therapy Affordable for the MassesThe revered wellness brand wields proven business savvy to innovate, disrupt and equalize through its...
-
February 21, 2022 How Long Until Psychedelic Stocks Payoff?Our resident Psychedelic Investor explores one of the biggest questions on minds of those investing...
-
February 18, 2022 Psychedelic Business Spotlight – February 18This week in psychedelic business news: Nova Mentis makes progress on autism; atai donates to...
-
February 17, 2022 Cybin Partners with The Chopra Foundation to Bring Awareness to the Benefits of Psychedelic-Based Therapies"The need for new and more effective treatments across the mental health spectrum is more...
-
February 16, 2022 Cathie Woods’ ARK Invest Conducting ‘Deep Dive’ Into Psychedelic StocksCathie Wood and Ark Invest buying psychedelic stocks will be significant for the industry, as...
